ANSMフランス供給不足情報(2025年1月27日~2025年2月2日)

IngredientsStatusUpdateSpecialty
fluoroestradiol (18F)Supply tension31/01/2025Estrotep 500 MBq/mL, solution for injection –
sodium clodronate anhydrousSupply tension31/01/2025Lytos 520 mg, film-coated tablet –
calcium (carbonate)Supply tension31/01/2025Calcidia 1.54 g, granulated oral suspension in dose sachet –
lenalidomideSupply tension31/01/2025Lenalidomide Mylan, capsule –
clofazimineAvailable again31/01/2025Lamprene 100 mg, soft capsule –
quetiapine (fumarate of)Supply tension30/01/2025Quetiapine LP (Xeroquel LP) 50 mg, 300 mg and 400 mg Prolonged-release tablet –
rifampicinSupply tension29/01/2025Rifadine 2%, drinkable suspension –
isoniazid, rifampinSupply tension29/01/2025Rifinah 300 mg/150 mg, coated tablet –
isoniazid, pyrazinamid, rifampicinSupply tension29/01/2025Rifater, Coated tablet –
somatotropinAvailable again29/01/2025Genotonorm 12 mg, powder and solvent for solution for injection box of 5 cartridges in GoQuick pre-filled pen –
rifampicinSupply tension29/01/2025Rifadine 300 mg, capsule –
rifampicinSupply tension29/01/2025Rifadine IV 600 mg, powder and solvent for solution for infusion –
methylphenidate (hydrochloride)Handover29/01/2025Methylphenidate Biogaran LP, extended-release tablet –
 Supply tension29/01/2025Exacyl 500 mg, film-coated tablet – (tranexamic acid)
daptomycinOut of stock29/01/2025Daptomycin Noridem 500 mg, powder for solution for injection/infusion in 10 ml vial –
magnesium (pidolate of)Supply tension28/01/2025Maginjectable 0.8 per cent, solution for injection –
emtricitabine/tenofovir disoproxilSupply tension28/01/2025Speciality based on emtricitabine/tenofovir disoproxil 200 mg/245 mg, film-coated tablet –
Iobenguane (¹³¹I)Marketing discontinuation28/01/2025Iobenguane (¹³¹I) for therapy CIS bio international 370 MBq/mL, solution for infusion –
spiramycin (adipate)Availability27/01/2025Rovamycin 1.5 million international units, lyophilisate for parenteral use –
oseltamivirSupply tension27/01/2025Tamiflu 75 mg, capsule –
2025年2月3日
このページの先頭へ戻る